Persistent URL of this record https://hdl.handle.net/1887/3279618
Documents
-
- Download
- 121248243_publishedVersion_None
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
- All authors
- Kroger, N.; Sbianchi, G.; Sirait, T.; Wolschke, C.; Beelen, D.; Passweg, J.; Robin, M.; Vrhovac, R.; Helbig, G.; Sockel, K.; Conneally, E.; Rubio, M.T.; Beguin, Y.; Finke, J.; Bernasconi, P.; Morozova, E.; Clausen, J.; Borne, P. von dem; Schaap, N.; Schroyens, W.; Patriarca, F.; Renzo, N. di; Yegin, Z.A.; Hayden, P.; McLornan, D.; Yakoub-Agha, I.
- Date
- 2021-05-22
- Journal
- Leukemia
- Volume
- 35
- Pages
- 3551 - 3560